{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:38:29Z","timestamp":1794955109752,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present article describes the design, synthesis, in vitro urease inhibition, and in silico molecular docking studies of a novel series of nitrothiazolacetamide conjugated to different thioquinazolinones. Fourteen nitrothiazolacetamide bearing thioquinazolinones derivatives (<jats:bold>8a-n<\/jats:bold>) were synthesized through the reaction of isatoic anhydride with different amine, followed by reaction with carbon disulfide and KOH in ethanol. The intermediates were then converted into final products by treating them with 2-chloro-N-(5-nitrothiazol-2-yl)acetamide in DMF. All derivatives were then characterized through different spectroscopic techniques (<jats:sup>1<\/jats:sup>H, <jats:sup>13<\/jats:sup>C-NMR, MS, and FTIR). In vitro screening of these molecules against urease demonstrated the potent urease inhibitory potential of derivatives with IC<jats:sub>50<\/jats:sub> values ranging between 2.22\u2009\u00b1\u20090.09 and 8.43\u2009\u00b1\u20090.61\u00a0\u03bcM when compared with the standard thiourea (IC<jats:sub>50<\/jats:sub>\u2009=\u200922.50\u2009\u00b1\u20090.44\u00a0\u03bcM). Compound <jats:bold>8h<\/jats:bold> as the most potent derivative exhibited an uncompetitive inhibition pattern against urease in the kinetic study. The high anti-ureolytic activity of <jats:bold>8h<\/jats:bold> was confirmed against two urease-positive microorganisms. According to molecular docking study, <jats:bold>8h<\/jats:bold> exhibited several hydrophobic interactions with Lys10, Leu11, Met44, Ala47, Ala85, Phe87, and Pro88 residues plus two hydrogen bound interactions with Thr86. According to the in silico assessment, the ADME-Toxicity and drug-likeness profile of synthesized compounds were in the acceptable range.<\/jats:p>","DOI":"10.1038\/s41598-022-05736-4","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T11:15:53Z","timestamp":1644232553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents"],"prefix":"10.1038","volume":"12","author":[{"given":"Marzieh","family":"Sohrabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Nazari Montazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Moghadam","family":"Farid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Tanideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Dianatpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Moazzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamiar","family":"Zomorodian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanesadat","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Biglar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud","family":"Amanlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh","family":"Barazandeh Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Iraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"5736_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jare.2018.01.007","volume":"13","author":"P Kafarski","year":"2018","unstructured":"Kafarski, P. & Talma, M. Recent advances in design of new urease inhibitors: A review. J. Adv. Res. 13, 101\u2013112 (2018).","journal-title":"J. Adv. Res."},{"key":"5736_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jare.2018.03.007","volume":"13","author":"\u00c2 de F\u00e1tima","year":"2018","unstructured":"de F\u00e1tima, \u00c2. et al. Schiff bases and their metal complexes as urease inhibitors: A brief review. J. Adv. Res. 13, 113\u2013126 (2018).","journal-title":"J. Adv. Res."},{"issue":"5","key":"5736_CR3","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1365-2958.1993.tb01220.x","volume":"9","author":"CM Collins","year":"1993","unstructured":"Collins, C. M. & D\u2019Orazio, S. E. Bacterial ureases: Structure, regulation of expression and role in pathogenesis. Mol. Microbiol. 9(5), 907\u2013913 (1993).","journal-title":"Mol. Microbiol."},{"issue":"6","key":"5736_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/35073084","volume":"2","author":"C Montecucco","year":"2001","unstructured":"Montecucco, C. & Rappuoli, R. Living dangerously: How Helicobacter pylori survives in the human stomach. Nat. Rev. Mol. Cell Biol. 2(6), 457\u2013466 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"5736_CR5","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1139\/o80-181","volume":"58","author":"NE Dixon","year":"1980","unstructured":"Dixon, N. E., Riddles, P. W., Gazzola, C., Blakeley, R. L. & Zerner, B. Jack bean urease (EC 3.5.1.5). V. On the mechanism of action of urease on urea, formamide, acetamide, N-methylurea, and related compounds. Can. J. Biochem. 58(12), 1335\u20131344 (1980).","journal-title":"Can. J. Biochem."},{"key":"5736_CR6","doi-asserted-by":"publisher","first-page":"364891","DOI":"10.1155\/2010\/364891","volume":"2010","author":"H Carlsson","year":"2010","unstructured":"Carlsson, H. & Nordlander, E. Computational modeling of the mechanism of urease. Bioinorg. Chem. Appl. 2010, 364891 (2010).","journal-title":"Bioinorg. Chem. Appl."},{"issue":"5213","key":"5736_CR7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.7754394","volume":"268","author":"SJ Lippard","year":"1995","unstructured":"Lippard, S. J. At last\u2013the crystal structure of urease. Science (New York, N.Y.) 268(5213), 996\u20137 (1995).","journal-title":"Science (New York, N.Y.)"},{"key":"5736_CR8","doi-asserted-by":"crossref","unstructured":"Mobley, H. L., Mendz, G. L.& Hazell, S. L. Helicobacter Pylori: Physiology and Genetics, (2001).","DOI":"10.1128\/9781555818005"},{"issue":"Sup1","key":"5736_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1046\/j.1365-2036.1996.22164006.x","volume":"10","author":"H Mobley","year":"1996","unstructured":"Mobley, H. The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration. Aliment. Pharmacol. Ther. 10(Sup1), 57\u201364 (1996).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"5736_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1128\/mr.59.3.451-480.1995","volume":"59","author":"H Mobley","year":"1995","unstructured":"Mobley, H., Island, M. D. & Hausinger, R. P. Molecular biology of microbial ureases. Microbiol. Rev. 59(3), 451\u2013480 (1995).","journal-title":"Microbiol. Rev."},{"key":"5736_CR11","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3389\/fmicb.2017.01883","volume":"8","author":"D Olivera-Severo","year":"2017","unstructured":"Olivera-Severo, D. et al. A new role for helicobacter pylori urease: Contributions to angiogenesis. Front. Microbiol. 8, 1883 (2017).","journal-title":"Front. Microbiol."},{"issue":"3","key":"5736_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jmb.2010.05.009","volume":"400","author":"A Balasubramanian","year":"2010","unstructured":"Balasubramanian, A. & Ponnuraj, K. Crystal structure of the first plant urease from jack bean: 83 years of journey from its first crystal to molecular structure. J. Mol. Biol. 400(3), 274\u2013283 (2010).","journal-title":"J. Mol. Biol."},{"key":"5736_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bioorg.2015.06.004","volume":"61","author":"A Hameed","year":"2015","unstructured":"Hameed, A. et al. Synthesis, biological evaluation and molecular docking of N-phenyl thiosemicarbazones as urease inhibitors. Bioorg. Chem. 61, 51\u201357 (2015).","journal-title":"Bioorg. Chem."},{"key":"5736_CR14","doi-asserted-by":"publisher","first-page":"104691","DOI":"10.1016\/j.bioorg.2021.104691","volume":"109","author":"M Islam","year":"2021","unstructured":"Islam, M. et al. Therapeutic potential of N4-substituted thiosemicarbazones as new urease inhibitors: Biochemical and in silico approach. Bioorg. Chem. 109, 104691 (2021).","journal-title":"Bioorg. Chem."},{"key":"5736_CR15","doi-asserted-by":"publisher","first-page":"104336","DOI":"10.1016\/j.bioorg.2020.104336","volume":"105","author":"A Hamad","year":"2020","unstructured":"Hamad, A. et al. Probing sulphamethazine and sulphamethoxazole based Schiff bases as urease inhibitors; synthesis, characterization, molecular docking and ADME evaluation. Bioorg. Chem. 105, 104336 (2020).","journal-title":"Bioorg. Chem."},{"key":"5736_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejmech.2018.06.065","volume":"156","author":"Q Liu","year":"2018","unstructured":"Liu, Q. et al. Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection. Eur. J. Med. Chem. 156, 126\u2013136 (2018).","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"5736_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cclet.2015.12.035","volume":"27","author":"F Rahim","year":"2016","unstructured":"Rahim, F. et al. Development of bis-thiobarbiturates as successful urease inhibitors and their molecular modeling studies. Chin. Chem. Lett. 27(5), 693\u2013697 (2016).","journal-title":"Chin. Chem. Lett."},{"issue":"23","key":"5736_CR18","doi-asserted-by":"publisher","first-page":"115759","DOI":"10.1016\/j.bmc.2020.115759","volume":"28","author":"HG Abdulwahab","year":"2020","unstructured":"Abdulwahab, H. G. et al. Novel thiobarbiturates as potent urease inhibitors with potential antibacterial activity: Design, synthesis, radiolabeling and biodistribution study. Bioorg. Med. Chem. 28(23), 115759 (2020).","journal-title":"Bioorg. Med. Chem."},{"key":"5736_CR19","doi-asserted-by":"publisher","first-page":"100396","DOI":"10.1016\/j.cdc.2020.100396","volume":"28","author":"I Uddin","year":"2020","unstructured":"Uddin, I. et al. Synthesis, in vitro alpha glucosidase, urease activities and molecular docking study of bis-indole bearing Schiff base analogs. Chem. Data Collect. 28, 100396 (2020).","journal-title":"Chem. Data Collect."},{"issue":"1","key":"5736_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-67414-7","volume":"10","author":"M Taha","year":"2020","unstructured":"Taha, M. et al. Synthesis, in vitro urease inhibitory potential and molecular docking study of benzofuran-based-thiazoldinone analogues. Sci. Rep. 10(1), 1\u20138 (2020).","journal-title":"Sci. Rep."},{"key":"5736_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bioorg.2016.04.005","volume":"66","author":"U Rashid","year":"2016","unstructured":"Rashid, U. et al. Synthesis of 2-acylated and sulfonated 4-hydroxycoumarins: In vitro urease inhibition and molecular docking studies. Bioorg. Chem. 66, 111\u2013116 (2016).","journal-title":"Bioorg. Chem."},{"key":"5736_CR22","doi-asserted-by":"publisher","first-page":"103024","DOI":"10.1016\/j.bioorg.2019.103024","volume":"89","author":"K Zaman","year":"2019","unstructured":"Zaman, K. et al. Synthesis, in vitro urease inhibitory potential and molecular docking study of Benzimidazole analogues. Bioorg. Chem. 89, 103024 (2019).","journal-title":"Bioorg. Chem."},{"key":"5736_CR23","doi-asserted-by":"publisher","first-page":"103112","DOI":"10.1016\/j.bioorg.2019.103112","volume":"91","author":"F Rahim","year":"2019","unstructured":"Rahim, F. et al. Synthesis of new arylhydrazide bearing Schiff bases\/thiazolidinone: \u03b1-Amylase, urease activities and their molecular docking studies. Bioorg. Chem. 91, 103112 (2019).","journal-title":"Bioorg. Chem."},{"issue":"1","key":"5736_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bmc.2017.11.028","volume":"26","author":"M Taha","year":"2018","unstructured":"Taha, M. et al. Bisindolylmethane thiosemicarbazides as potential inhibitors of urease: Synthesis and molecular modeling studies. Bioorg. Med. Chem. 26(1), 152\u2013160 (2018).","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"5736_CR25","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1016\/j.bmc.2018.06.005","volume":"26","author":"MA Abbasi","year":"2018","unstructured":"Abbasi, M. A. et al. Synthesis, in vitro and in silico studies of novel potent urease inhibitors: N-[4-({5-[(3-Un\/substituted-anilino-3-oxopropyl) sulfanyl]-1, 3, 4-oxadiazol-2-yl} methyl)-1, 3-thiazol-2-yl] benzamides. Bioorg. Med. Chem. 26(13), 3791\u20133804 (2018).","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"5736_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1752-153X-7-95","volume":"7","author":"D Wang","year":"2013","unstructured":"Wang, D. & Gao, F. Quinazoline derivatives: Synthesis and bioactivities. Chem. Cent. J. 7(1), 95 (2013).","journal-title":"Chem. Cent. J."},{"key":"5736_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejmech.2014.10.084","volume":"90","author":"I Khan","year":"2015","unstructured":"Khan, I., Ibrar, A., Ahmed, W. & Saeed, A. Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: the advances continue. Eur. J. Med. Chem. 90, 124\u2013169 (2015).","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"5736_CR28","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.bmc.2016.03.031","volume":"24","author":"I Khan","year":"2016","unstructured":"Khan, I. et al. Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: An update on the development of synthetic methods and pharmacological diversification. Bioorg. Med. Chem. 24(11), 2361\u20132381 (2016).","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"5736_CR29","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jsps.2017.04.022","volume":"25","author":"HA Abuelizz","year":"2017","unstructured":"Abuelizz, H. A., Marzouk, M., Ghabbour, H. & Al-Salahi, R. Synthesis and anticancer activity of new quinazoline derivatives. Saudi Pharm. J. 25(7), 1047\u20131054 (2017).","journal-title":"Saudi Pharm. J."},{"issue":"11","key":"5736_CR30","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1016\/j.ejmech.2010.07.067","volume":"45","author":"AM Alafeefy","year":"2010","unstructured":"Alafeefy, A. M., Kadi, A. A., Al-Deeb, O. A., El-Tahir, K. E. & Al-Jaber, N. A. Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives. Eur J Med Chem 45(11), 4947\u20134952 (2010).","journal-title":"Eur J Med Chem"},{"issue":"10","key":"5736_CR31","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1021\/jm00364a014","volume":"26","author":"E Honkanen","year":"1983","unstructured":"Honkanen, E. et al. Synthesis and antihypertensive activity of some new quinazoline derivatives. J. Med. Chem. 26(10), 1433\u20131438 (1983).","journal-title":"J. Med. Chem."},{"issue":"68","key":"5736_CR32","doi-asserted-by":"publisher","first-page":"41353","DOI":"10.1039\/D0RA06642G","volume":"10","author":"PS Auti","year":"2020","unstructured":"Auti, P. S., George, G. & Paul, A. T. Recent advances in the pharmacological diversification of quinazoline\/quinazolinone hybrids. RSC Adv. 10(68), 41353\u201341392 (2020).","journal-title":"RSC Adv."},{"issue":"1","key":"5736_CR33","first-page":"1","volume":"11","author":"E Jafari","year":"2016","unstructured":"Jafari, E., Khajouei, M. R., Hassanzadeh, F., Hakimelahi, G. H. & Khodarahmi, G. A. Quinazolinone and quinazoline derivatives: Recent structures with potent antimicrobial and cytotoxic activities. Res. Pharm. Sci. 11(1), 1\u201314 (2016).","journal-title":"Res. Pharm. Sci."},{"key":"5736_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bioorg.2018.06.011","volume":"80","author":"G Aky\u00fcz","year":"2018","unstructured":"Aky\u00fcz, G., Mente\u015fe, E., Emirik, M. & Balta\u015f, N. Synthesis and molecular docking study of some novel 2, 3-disubstituted quinazolin-4 (3H)-one derivatives as potent inhibitors of urease. Bioorg. Chem. 80, 121\u2013128 (2018).","journal-title":"Bioorg. Chem."},{"key":"5736_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.bioorg.2018.10.031","volume":"83","author":"E Mente\u015fe","year":"2019","unstructured":"Mente\u015fe, E., Aky\u00fcz, G., Emirik, M. & Balta\u015f, N. Synthesis, in vitro urease inhibition and molecular docking studies of some novel quinazolin-4 (3H)-one derivatives containing triazole, thiadiazole and thiosemicarbazide functionalities. Bioorg. Chem. 83, 289\u2013296 (2019).","journal-title":"Bioorg. Chem."},{"key":"5736_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejmech.2015.12.022","volume":"109","author":"D Das","year":"2016","unstructured":"Das, D., Sikdar, P. & Bairagi, M. Recent developments of 2-aminothiazoles in medicinal chemistry. Eur. J. Med. Chem. 109, 89\u201398 (2016).","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"5736_CR37","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1016\/j.bmcl.2010.04.126","volume":"20","author":"TE Ballard","year":"2010","unstructured":"Ballard, T. E. et al. Biological activity of modified and exchanged 2-amino-5-nitrothiazole amide analogues of nitazoxanide. Bioorg. Med. Chem. Lett. 20(12), 3537\u20133539 (2010).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"5736_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29161\/PT.v6.i9.2018.1","volume":"6","author":"M Shrivastava","year":"2018","unstructured":"Shrivastava, M., Shrivastava, G. & Shrivastava, G. Antimicrobial activity of schiff base of 2-Amino 5-nitrothiazole and its copper complex. PharmaTutor 6(9), 1\u20135 (2018).","journal-title":"PharmaTutor"},{"issue":"12","key":"5736_CR39","doi-asserted-by":"publisher","first-page":"1800182","DOI":"10.1002\/ardp.201800182","volume":"351","author":"E Mente\u015fe","year":"2018","unstructured":"Mente\u015fe, E., Aky\u00fcz, G., Y\u0131lmaz, F., Balta\u015f, N. & Emirik, M. Synthesis of some novel quinazolin-4 (3H)-one hybrid molecules as potent urease inhibitors. Arch. Pharm. 351(12), 1800182 (2018).","journal-title":"Arch. Pharm."},{"issue":"4","key":"5736_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000007200","volume":"45","author":"Y Yamamoto","year":"1999","unstructured":"Yamamoto, Y. et al. Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity. Chemotherapy 45(4), 303\u2013312 (1999).","journal-title":"Chemotherapy"},{"key":"5736_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bioorg.2018.10.018","volume":"83","author":"MA Abbasi","year":"2019","unstructured":"Abbasi, M. A. et al. Synthesis of novel N-(1,3-thiazol-2-yl)benzamide clubbed oxadiazole scaffolds: Urease inhibition, Lipinski rule and molecular docking analyses. Bioorg. Chem. 83, 63\u201375 (2019).","journal-title":"Bioorg. Chem."},{"key":"5736_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jare.2018.05.003","volume":"13","author":"YF Rego","year":"2018","unstructured":"Rego, Y. F. et al. A review on the development of urease inhibitors as antimicrobial agents against pathogenic bacteria. J. Adv. Res. 13, 69\u2013100 (2018).","journal-title":"J. Adv. Res."},{"issue":"14","key":"5736_CR43","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2174\/0929867023369853","volume":"9","author":"Z Amtul","year":"2002","unstructured":"Amtul, Z., Siddiqui, R. & Choudhary, M. Chemistry and mechanism of urease inhibition. Curr. Med. Chem. 9(14), 1323\u20131348 (2002).","journal-title":"Curr. Med. Chem."},{"key":"5736_CR44","doi-asserted-by":"publisher","first-page":"116044","DOI":"10.1016\/j.bmc.2021.116044","volume":"36","author":"N Sepehri","year":"2021","unstructured":"Sepehri, N. et al. The natural-based optimization of kojic acid conjugated to different thio-quinazolinones as potential anti-melanogenesis agents with tyrosinase inhibitory activity. Bioorg. Med. Chem. 36, 116044 (2021).","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"5736_CR45","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires, D. E. V., Blundell, T. L. & Ascher, D. B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58(9), 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"5736_CR46","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"issue":"9","key":"5736_CR47","doi-asserted-by":"publisher","first-page":"e2000023","DOI":"10.1002\/ardp.202000023","volume":"353","author":"MS Asgari","year":"2020","unstructured":"Asgari, M. S. et al. New 1,2,3-triazole-(thio)barbituric acid hybrids as urease inhibitors: Design, synthesis, in vitro urease inhibition, docking study, and molecular dynamic simulation. Arch. Pharm. (Weinheim) 353(9), e2000023 (2020).","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"1","key":"5736_CR48","doi-asserted-by":"publisher","first-page":"10607","DOI":"10.1038\/s41598-021-90104-x","volume":"11","author":"K Pedrood","year":"2021","unstructured":"Pedrood, K. et al. Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors. Sci. Rep. 11(1), 10607 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"5736_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11224-020-01617-6","volume":"32","author":"S Sedaghati","year":"2021","unstructured":"Sedaghati, S. et al. Novel (thio)barbituric-phenoxy-N-phenylacetamide derivatives as potent urease inhibitors: synthesis, in vitro urease inhibition, and in silico evaluations. Struct. Chem. 32(1), 37\u201348 (2021).","journal-title":"Struct. Chem."},{"key":"5736_CR50","unstructured":"Maestro, Schr\u00f6dinger, LLC, (2021)."},{"issue":"3","key":"5736_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27(3), 221\u2013234 (2013).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"5736_CR52","unstructured":"S. LigPrep, LLC (2021)."},{"issue":"6","key":"5736_CR53","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","volume":"24","author":"JR Greenwood","year":"2010","unstructured":"Greenwood, J. R., Calkins, D., Sullivan, A. P. & Shelley, J. C. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution. J. Comput. Aided Mol. Des. 24(6), 591\u2013604 (2010).","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"9","key":"5736_CR54","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.bmc.2005.12.032","volume":"14","author":"R Farid","year":"2006","unstructured":"Farid, R., Day, T., Friesner, R. A. & Pearlstein, R. A. New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. Bioorg. Med. Chem. 14(9), 3160\u20133173 (2006).","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"5736_CR55","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/ci800324m","volume":"49","author":"TA Halgren","year":"2009","unstructured":"Halgren, T. A. Identifying and characterizing binding sites and assessing druggability. J. Chem. Inf. Model. 49(2), 377\u2013389 (2009).","journal-title":"J. Chem. Inf. Model."},{"issue":"21","key":"5736_CR56","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A. et al. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212 ligand complexes. J. Med. Chem. 49(21), 6177\u20136196 (2006).","journal-title":"J. Med. Chem."},{"key":"5736_CR57","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jpba.2018.02.003","volume":"152","author":"P Knezevic","year":"2018","unstructured":"Knezevic, P., Aleksic Sabo, V., Simin, N., Lesjak, M. & Mimica-Dukic, N. A colorimetric broth microdilution method for assessment of Helicobacter pylori sensitivity to antimicrobial agents. J. Pharm. Biomed. Anal. 152, 271\u2013278 (2018).","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1\u20132","key":"5736_CR58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1439-0507.1998.tb00374.x","volume":"41","author":"Y Nakamura","year":"1998","unstructured":"Nakamura, Y., Kano, R., Watanabe, S., Takahashi, H. & Hasegawa, A. Susceptibility testing of cryptococcus neoformans using the urea broth microdilution method: Empfindlichkeitspr\u00fcfung von cryptococcus neoformans in Harnstoff-Bouillon mittels Mikrodilution. Mycoses 41(1\u20132), 41\u201344 (1998).","journal-title":"Mycoses"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05736-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:07:24Z","timestamp":1669327644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05736-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5736"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05736-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"5 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2003"}}